Loading…
Wednesday, June 26 • 8:00am - 9:15am
#305: Demystifying Technology Selection in Mobile Clinical Trials

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-19-661-L04-P; CME 1.25; IACET 1.25; RN 1.25

This session will describe CTTI resources that support the adoption of mobile technologies into clinical research by 1) eliminating redundant feasibility testing, and 2) promoting streamlined, informative studies where there are knowledge gaps.

Learning Objectives

Describe how feasibility testing can reduce the risk of conducting mobile clinical trials; Identify how to initiate their own feasibility studies, where appropriate; Describe how to access and utilize the consortium's database of feasibility studies available as a resource summarizing current knowledge.

Chair

Thomas Switzer, MEd

Speaker

FDA Perspective
Isaac R. Rodriguez-Chavez, MHS, PhD, MS

Industry Update
Barry Peterson, PhD

Panelist
Aaron Coleman



Speakers
AC

Aaron Coleman

Founder and Chief Executive Officer, Fitabase
In 2012 Aaron Coleman founded Fitabase, forming an early partnership with Fitbit and creating a software platform to connect consumer devices to the needs of researchers and data scientists. Fitabase has been used by over 500 research studies, clinical care pilots, and pharma trials... Read More →
avatar for Barry Peterson

Barry Peterson

Wearable Devices, Independent Consultant
Dr. Peterson has extensive experience with the application of actigraphy and physiological measurements in pharmaceutical clinical trials. After 20 years of academic research on acute lung injury and respiratory measurement techniques, he joined Pfizer's Clinical Technology group... Read More →
avatar for Isaac Rodriguez-Chavez

Isaac Rodriguez-Chavez

Clinical Research Methodology, Reg Compliance and Policy Development, OMP, CDER, FDA
Dr. Isaac R. Rodriguez-Chavez serves as a FDA, CDER Officer for Clinical Research Methodology, Regulatory Compliance and Policy Development. He is a biomedical leader with expertise in Virology, Microbiology, Immunology, Vaccinology, and Oncology. Past positions in the last 20 years... Read More →
avatar for Thomas Switzer

Thomas Switzer

Business Ops Leader, Digital Health Platforms, Genentech, A Member of the Roche Group
Tom is a Business Operations Lead in the Roche PHC Center of Excellence supporting Digital Health Platforms.  His current focus is on developing technology platforms supporting molecule teams across the Roche late-stage organization.  Tom has over 18 years of clinical development... Read More →


Wednesday June 26, 2019 8:00am - 9:15am
Room 9 San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  • Level Intermediate
  • Featured Topics Innovative Trial Design
  • Credit Type ACPE, CME, IACET, RN
  • Tags Session